MedTrace Logo

A Study to Evaluate the Effects of a Prostate Health Formulation

NCT02886832 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-04-18

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of a Prostate Health formulation on scores attained from the I-PSS questionnaire. Safety and tolerability of the formulation will also be assessed.

Conditions

  • Prostate Health

Interventions

DIETARY_SUPPLEMENT

Prostate Health formulation

Sponsors & Collaborators

  • Supplement Formulators, Inc.

    lead INDUSTRY

Principal Investigators

  • Steven Joyal, M.D. · Life Extension

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-21
Primary Completion
2018-02-27
Completion
2018-03-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02886832 on ClinicalTrials.gov